Nektar Therapeutics (NKTR) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped NKTR stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: Nektar Therapeutics represents a high-risk, high-reward investment opportunity primarily driven by its promising pipeline assets and strong analyst favor. Its positive FDA Fast Track designation, expanded R&D partnerships, and recent trial results contribute to bullish sentiment. Financial and competitive risks should not be ignored, but these are outweighed by mid-to-long term growth potential. The saved 1-year distribution is P10 $50, P50 $95.4, and P90 $140.25.
Last analyzed · Model: gpt-4o
Nektar Therapeutics Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $50 | Pessimistic plausible scenario |
| P50 | $95.4 | Median scenario |
| P90 | $140.25 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
Recent positive developments in R&D partnerships and a promising FDA Fast Track designation set a strong bullish case. Although the financials such as earnings show losses, analysts are highly optimistic with a strong buy recommendation and high mean target, suggesting good growth potential. Some bearish sentiment arises from regulatory scrutiny and volatility warnings.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this NKTR analysis generated?
June 8, 2026.
Is this a guaranteed NKTR prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full NKTR stock analysis · NKTR sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.